Related Experiment Video
Updated: Aug 13, 2026

07:15
Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model
Published on: August 16, 2020
Dosimetric parameter-based machine learning to predict radiation pneumonitis following breast radiotherapy
Hamid Ghaznavi1, Farzaneh Allaveisi2, Ziad Saleh1
1Department of Radiation Oncology, WashU Medicine, St. Louis, MO 63110, United States of America.
Physics in Medicine and Biology
|August 12, 2026
Summary
Machine learning models effectively predict radiation pneumonitis (RP) after breast radiotherapy using lung dosimetric data. High-dose lung parameters are key predictors, enabling personalized treatment and early risk identification for patients.
Area of Science:
- Radiation oncology
- Medical physics
- Machine learning in healthcare
Background:
- Radiation pneumonitis (RP) is a significant toxicity after breast radiotherapy.
- Predicting which patients will develop symptomatic RP remains challenging despite modern techniques.
- Accurate prediction is crucial for personalized treatment planning and patient management.
Purpose of the Study:
- To develop and validate machine learning (ML) models for predicting clinically significant RP.
- To utilize ipsilateral-lung dosimetric parameters for prediction.
- To assess the role of high-dose versus low-dose lung exposure in RP risk.
Main Methods:
- Retrospective study of 184 breast cancer patients treated with 3D-CRT.
- Extraction of ipsilateral lung dose-volume metrics, Dmax, MLD, and Deff.
- Training and cross-validation of four ML models (LightGBM, random forest, SVM, logistic regression).
Main Results:
- 28% of patients developed clinically significant RP (CTCAE grade >=2).
- All four ML models demonstrated strong predictive performance (AUC >0.8).
- High-dose lung parameters (e.g., V45Gy, Dmax) were the most significant predictors.
Conclusions:
- ML models using routine lung dosimetric data can predict RP post-breast radiotherapy.
- Higher doses to smaller lung regions are more critical for RP risk than low-dose exposure.
- This approach can aid personalized treatment planning and identify at-risk patients for closer monitoring.

